| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1210/JCEM.86.7.7683 |
| P698 | PubMed publication ID | 11443168 |
| P50 | author | Kerstin Albertsson Wikland | Q4934775 |
| P2093 | author name string | P Saenger | |
| R Rosenfeld | |||
| A Lin | |||
| M B Ranke | |||
| C H Gravholt | |||
| O Hovatta | |||
| M Davenport | |||
| M Hultcrantz | |||
| K Landin-Wilhelmsen | |||
| A M Pasquino | |||
| M Silberbach | |||
| G S Conway | |||
| B Lippe | |||
| Fifth International Symposium on Turner Syndrome | |||
| R Hintz | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3061-3069 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Recommendations for the diagnosis and management of Turner syndrome | |
| P478 | volume | 86 |
| Q39559152 | A Rare Variant of Turner Syndrome in Four Sequential Generations: Effect of the Interplay of Growth Hormone Treatment and Estrogens on Body Proportion |
| Q37147401 | A Track Record on SHOX: From Basic Research to Complex Models and Therapy |
| Q42281616 | A case of 45,X/47,XXX mosaic Turner syndrome with limb length discrepancy |
| Q37978219 | A review of guidelines for use of growth hormone in pediatric and transition patients |
| Q36951783 | A unique case of Turner syndrome accompanying prolactinoma and unexpected elongated styloid process: Clinical and cone-beam computed tomographic features |
| Q36943136 | Adult heights of 258 girls with turner syndrome on low dose of growth hormone therapy in Japan |
| Q35686965 | An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population |
| Q37974585 | Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency |
| Q80647972 | Aortic dissecting aneurysm with a bicuspid aortic valve in Turner's syndrome: report of a case |
| Q34436530 | Bone age is the best predictor of growth response to recombinant human growth hormone in Turner's syndrome |
| Q26775611 | Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome |
| Q33697565 | Care of girls and women with Turner syndrome: beyond growth and hormones. |
| Q38262917 | Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. |
| Q34296411 | Cornelia de Lange syndrome with NIPBL mutation and mosaic Turner syndrome in the same individual |
| Q81621595 | Cytogenetics findings at Turner Syndrome and their correlation with clinical findings |
| Q92904097 | Delayed Puberty-Phenotypic Diversity, Molecular Genetic Mechanisms, and Recent Discoveries |
| Q90622566 | Depression in Turner Syndrome: A Systematic Review |
| Q55082008 | Diagnosis of a Chinese man with 45,X/46,X,i(Y)(q10)/47,X,i(Y) (q10) ×2 mosaic Turner syndrome. |
| Q57048301 | Diet and Lifestyle Role in Homocysteine Metabolism in Turner's Syndrome |
| Q38747000 | Early Bilateral Gonadoblastoma in a Young Child with Mosaicism for Turner Syndrome and Trisomy 18 with Y Chromosome |
| Q92107307 | Editorial: Epigenetics in Mammalian Tissues |
| Q34130891 | Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial |
| Q37472914 | Endocrine and musculoskeletal abnormalities in patients with Down syndrome |
| Q38154505 | Energy metabolism and fertility: a balance preserved for female health |
| Q49333004 | FSH may be a useful tool to allow early diagnosis of Turner syndrome |
| Q36974600 | Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome |
| Q37139423 | Fracture risk and bone mineral density in Turner syndrome |
| Q59138519 | Genes underlying delayed puberty |
| Q37467938 | Genetic issues in the care of the adolescent patient |
| Q34868417 | Growth hormone plus childhood low-dose estrogen in Turner's syndrome |
| Q81503908 | Growth hormone therapy |
| Q55405892 | Health status, quality of life and medical care in adult women with Turner syndrome. |
| Q39175827 | High androgen levels protect against hypothyroidism. |
| Q41075163 | Identification of Y-Chromosome Sequences in Turner Syndrome |
| Q30405632 | Imaging of cardiovascular risk in patients with Turner's syndrome |
| Q82865268 | Ischemic stroke in a young adult with Turner syndrome |
| Q92212585 | Lack of consensus in the choice of termination of pregnancy for Turner syndrome in France |
| Q47173542 | Measured parental height in Turner syndrome-a valuable but underused diagnostic tool |
| Q55453772 | Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study. |
| Q36377815 | Mosaic triple X syndrome in a female with primary amenorrhea |
| Q92144162 | Needle-Free and Needle-Based Growth Hormone Therapy in Children: A Pooled Analysis of Three Long-Term Observational Studies |
| Q36106143 | New Genetic Insights into Congenital Heart Disease |
| Q36324342 | New issues in the diagnosis and management of Turner syndrome |
| Q60297014 | Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone |
| Q35636238 | Oral and craniofacial clinical signs associated to genetic conditions in human identification part I: a review. |
| Q26828838 | Precocious puberty in Turner Syndrome: report of a case and review of the literature |
| Q37732759 | Prediction of pubertal growth at start of estrogen replacement therapy in turner syndrome |
| Q38700265 | Prevalence and Physical Distribution of SRY in the Gonads of a Woman with Turner Syndrome: Phenotypic Presentation, Tubal Formation, and Malignancy Risk |
| Q79886551 | QTc interval prolongation in children with Ulrich-Turner syndrome |
| Q33635201 | Response to three years of growth hormone therapy in girls with Turner syndrome |
| Q36066629 | Short stature and growth hormone |
| Q76383866 | Short stature in children with an apparently normal male phenotype can be caused by 45,X/46,XY mosaicism and is susceptible to growth hormone treatment |
| Q36269610 | Spontaneous pregnancies in a Turner syndrome woman with Y-chromosome mosaicism |
| Q36292010 | The Role of the Geneticist and Genetic Counselor in an ACHD Clinic |
| Q34002089 | The evaluation and followup of children referred to pediatric endocrinologists for short stature |
| Q93031139 | Time to consider ovarian tissue cryopreservation for girls with Turner's syndrome: an opinion paper |
| Q35680677 | Turner syndrome and sexual differentiation of the brain: implications for understanding male-biased neurodevelopmental disorders |
| Q41672469 | Turner syndrome caused by rare complex structural abnormalities involving chromosome X. |
| Q37147327 | Turner syndrome: searching for better outcomes |
| Q82776041 | Twenty classic hand radiographs that lead to diagnosis |
| Q33772771 | Unreliability of aortic size index to predict risk of aortic dissection in a patient with Turner syndrome |
| Q36227812 | Uterine development in Turner syndrome |
Search more.